Heidi Hagen Insider Profile

4 Followers
Heidi Hagen, Director at Vericel, holds 1.75K shares in Vericel (Ticker: VCEL), holds 32.12K shares in Ziopharm Oncology (Ticker: ZIOP).
tipranks
Heidi Hagen

Heidi Hagen
Vericel (VCEL)
Director

Not Ranked
Heidi Hagen has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$138K
67.94%
32.06%
A breakdown of Heidi Hagen's holdings

Insider Roles

Ziopharm Oncology
(ZIOP)
Director
Vericel
(VCEL)
Director
Roles that Heidi Hagen holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Heidi Hagen

Heidi Hagen's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Vericel
May 01, 2020
Director
Uninformative Buy
$44.10K
Ziopharm Oncology
Jan 03, 2020
Director
Uninformative Buy
$93.47K
List of latest transactions for each holding click on a transaction to see Heidi Hagen's performance on stock

Heidi Hagen insider profile FAQ

What is the percentage of profitable transactions made by Heidi Hagen?
The percentage of profitable transactions made by Heidi Hagen is ―.
    What is the average return per transaction made by Heidi Hagen?
    The average return per transaction made by Heidi Hagen is ―.
      What stocks does Heidi Hagen hold?
      Heidi Hagen holds: VCEL, ZIOP stocks.
        What was Heidi Hagen’s latest transaction?
        Heidi Hagen latest transaction was an Uninformative Buy of ―.
          What was Heidi Hagen's most profitable transaction?
          Heidi Hagen’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Heidi Hagen's role in Vericel?
            Heidi Hagen's role in Vericel is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.